Net loss for the Group of €12.7m in 2019, an improvement of €0.9m compared to 2018 Cash position of €16.6 million at 31 December 2019 Ms. Corinne Granger joins the…
Evry (France), 17 October 2019 – Publication of half-year financial statements as at 30 June 2019, audited and adopted by the Board of Directors at today’s meeting. The report for…
Evry (France), 2 October 2019 Global Bioenergies will soon be receiving €2.6 million and IBN-One €0.5 million in the form of repayable advances, following last July’s achievement of a technical…
Evry (France), 05 September 2019 Further to today’s Annual General Meeting, Global Bioenergies announced that BOLD Business Opportunities for L’Oréal Development, now the largest shareholder following the financing transaction of last…
Evry (France) – 26 July 2019 – Global Bioenergies (Alternext Paris: ALGBE) presents the half-year report on the liquidity contract entrusted to the brokerage firm Gilbert Dupont. The following assets…
Evry (France), 25 July 2019 – Global Bioenergies has announced that it will hold a shareholder’s meeting on 5 September 2019 at 3pm at its offices located at 5, rue…
Evry (France), on 26 June 2019 Global Bioenergies (the “Company“) announces today having successfully closed its capital increase, launched on 20 June 2019 and conducted through a public offer without…
Participate Capital increase without preferential subscription rights and without priority subscription period through a public offer of an initial amount of €17 million, that may be increased up to €5…
Evry (France), 18 April 2019 As today’s General Meeting of Shareholders came to an end, Global Bioenergies announced the election of two new independent directors to the Board: Pierre Lévi,…
Evry (France), 9 April 2019 – Global Bioenergies (Euronext Growth: ALGBE) has announced having received a payment of €2.2 million for the OPTISOCHEM project supported by the Bio-Based Industries Joint…
We use cookies to guarantee you the best experience on our site. If you continue to use the latter, we will consider that you accept the use of cookies.OkLearn more